Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 5.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 002F00 | Y. Shimizu [Japon] ; E. Tanaka [Japon] ; E. Inoue [Japon] ; K. Shidara [Japon] ; D. Hoshi [Japon] ; N. Sugimoto [Japon] ; E. Sato [Japon] ; Y. Seto [Japon] ; S. Momohara [Japon] ; A. Nakajima [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon] | FRI0096 Influence of dose titration of concomitant steroid and methotrexate during biologic therapy on remission rates in patients with rheumatoid arthritis according to the new ACR/EULAR remission criteria in daily practice based on the iorra cohort |
| 002F11 | K. Shidara [Japon] ; A. Nakajima [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; E. Tanaka [Japon] ; Y. Inoue [Japon] ; A. Kobayashi [Japon] ; Y. Seto [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon] | FRI0068 Sustaining remission as defined by the new acr/eular criteria leads to better quality of life in patients with rheumatoid arthritis |
| 002F14 | K. Ochi [Japon] ; E. Tanaka [Japon] ; K. Shidara [Japon] ; K. Ikari [Japon] ; A. Nakajima [Japon] ; A. Taniguchi [Japon] ; S. Momohara [Japon] ; H. Yamanaka [Japon] | FRI0065 Clinical factors associated with the progression of functional impairment in rheumatoid arthritis patients who maintained the remission criteria defined by the new acr/eular criteria |
| 003127 | E. Tanaka [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; A. Kobayashi [Japon] ; N. Sugimoto [Japon] ; K. Shidara [Japon] ; E. Sato [Japon] ; Y. Seto [Japon] ; A. Nakajima [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon] | AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database |
| 003221 | E. Tanaka [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; K. Shidara [Japon] ; E. Sato [Japon] ; Y. Inoue [Japon] ; Y. Seto [Japon] ; A. Nakajima [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon] | AB0308 Optimal timing for tocilizumab administration to patients with rheumatoid arthritis in japan based on a cost-effectiveness analysis using the iorra cohort study |
| This area was generated with Dilib version V0.6.34. |  |